Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
A Phase I/II Investigation of Safety and Efficacy of Nivolumab and nab-Sirolimus in Patients With a Variety of Tumors With Genetic Mutations in the mTOR Pathway.
Anticancer Res. 2023 May;43(5):1993-2002. doi: 10.21873/anticanres.16360.
Anticancer Res. 2023.
PMID: 37097693
Clinical Trial.
SAINT: A Phase I/Expanded Phase II Study Using Safe Amounts of Ipilimumab, Nivolumab and Trabectedin as First-Line Treatment of Advanced Soft Tissue Sarcoma.
Gordon EM, Chawla SP, Tellez WA, Younesi E, Thomas S, Chua-Alcala VS, Chomoyan H, Valencia C, Brigham DA, Moradkhani A, Quon D, Srikureja A, Wong SG, Tseng W, Federman N.
Gordon EM, et al. Among authors: chua alcala vs.
Cancers (Basel). 2023 Jan 31;15(3):906. doi: 10.3390/cancers15030906.
Cancers (Basel). 2023.
PMID: 36765863
Free PMC article.
Item in Clipboard
Cite
Cite